Bénéfice Avant Impôts Changement Date
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Arrowhead Research USD 28.27M 7.85M 2025-12
Astellas Pharma JPY 48.02B 85.93B 2026-03
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Celltrion KRW 10.5B 4.1B 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Exelixis USD 267.69M 15M 2026-03
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Moderna USD -799M 612M 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 3.84B 802M 2026-03
Omeros USD -65.12M 21.27M 2024-06
OPKO Health USD -46.9M 88.33M 2025-12
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pfizer USD 5.18B 6.82B 2026-03
Pharma Mar EUR 1.6M 38.6M 2026-03
PTC Therapeutics USD -2.46M 136.62M 2026-03
Qiagen NV USD 109.17M 25.56M 2025-12
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Sartorius EUR 157.8M 76.1M 2026-03
Tilray USD -39.96M 39.19M 2025-09
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03